Skip Over Navigation Links
National Institutes of Health
:

Clinical Trials

Depression

Featured Studies

Featured studies include only those currently recruiting participants. They are listed according to the date they were added to the ClinicalTrials.gov registry, with the most recent studies appearing first.

  • Interpersonal Therapy Program for Preventing Postpartum Depression.
    Interventional study. This study will evaluate the effectiveness of an interpersonal therapy treatment called the Postpartum Prevention Program in preventing the development of postpartum depression in pregnant women who are financially disadvantaged. Ages 18-40. Locations in Pawtucket, RI; Providence, RI; Woonsocket, RI.
  • Combining Medications to Enhance Depression Outcomes.
    Interventional study. This study will compare whether a combination of antidepressant medications is better than one antidepressant medication alone when given as initial treatment for people with chronic or recurrent major depressive disorder. Ages 18-75. Locations in Tuscaloosa, AL; Harbor City, CA; Los Angeles, CA; San Diego, CA; Chicago, IL; Wichita, KS; Salem, MA; Ann Arbor, MI; Chapel Hill, NC; New York, NY; Tulsa, OK; Pittsburgh, PA; Nashville, TN; Dallas, TX; Richmond, VA.
  • Evaluating the Effects of Stress in Pregnancy.
    Evaluation study. This study will evaluate pregnant women with a past or current diagnosis of depression or anxiety to gain a better understanding of how these disorders can affect an infant's development, both during and after pregnancy. Ages 18-45. Location in Atlanta, GA.
  • Antidepressant Safety in Kids (ASK) Study.
    Evaluation study. This study will evaluate the risks and benefits of treatment with a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor in children and adolescents with a pre-specified anxiety disorder, depressive disorder, eating disorder, or obsessive-compulsive disorder. Ages 7-17. Location in Durham, NC.
  • Identifying Factors That Predict Antidepressant Treatment Response.
    Interventional study. This study will identify factors that may predict treatment response by comparing the effectiveness of three antidepressant treatments (two antidepressant medications and cognitive behavior therapy) in people with major depressive disorder. Ages 18-65. Location in Atlanta, GA.
  • Identification and Therapy of Postpartum Depression.
    Interventional study. This study will evaluate the effectiveness of a telephone-based depression screening and care management program in treating depression in postpartum women. Ages 18 and over. Location in Pittsburgh, PA.
  • Bipolar II Depression: Lithium, SSRI, or the Combination.
    Interventional study. This study will compare the safety and effectiveness of a mood stabilizing medication, an antidepressant medication, and a combination of both medications to treat symptoms of bipolar type II depression. Ages 18-65. Locations in Los Angeles, CA; Cincinnati, OH; Dallas, TX.
  • Genetics of Recurrent Early Onset Major Depression.
    Evaluation study. This study will identify specific genes that may cause a predisposition to depression in some families. Ages 21-70. Locations in Palo Alto, CA; Washington, DC; Iowa City, IA; Chicago, IL; Baltimore, MD; New York, NY.
  • Maintenance Treatment of Bipolar Depression.
    Interventional study. This study will compare two different antidepressant treatment regimens to determine which is more effective in reducing symptoms of bipolar depression. Ages 18 and over. Location in San Antonio, TX.
  • Effect of Family-Based Prevention on Children of Depressed Parents.
    Interventional study. This study will test the Protecting Families Program, a 10-week prevention program for depressed parents and their pre-teenage children, by comparing the effectiveness of the program versus parent training alone. Ages 9 and over. Location in Philadelphia, PA.
  • Magnetic Brain Stimulation for the Treatment of Adult Depression.
    Interventional study. This study will evaluate the safety and effectiveness of magnetic brain stimulation for the treatment of major depression in depressed adults with moderate treatment resistance. Ages 21-70. Locations in Atlanta, GA; New York, NY; Charleston, SC; Seattle, WA.
  • Cognitive Therapy for Recurrent Depression.
    Interventional study. This study will determine the effectiveness of continuation phase cognitive therapy versus antidepressant medication in preventing relapse of depression in people with recurrent depression. Ages 18-70. Locations in Pittsburgh, PA; Dallas, TX.
  • Hormone and Sleep Response to Antidepressant Treatment in Adolescents and Adults With Depression.
    Interventional study. This study will determine whether there are age-related differences in the body systems controlling sleep and stress hormone patterns. This study will also determine whether the differences in sleep and hormone patterns between depressed adolescents and adults are associated with differences in their response to antidepressant treatment. Ages 12-50. Location in Dallas, TX.
  • Medication Treatment for Depression in Nursing Home Residents.
    Interventional study. This study will examine therapeutic and adverse effects of continuing versus discontinuing antidepressant medication in nursing home residents who have had no more than a single episode of depression and who no longer have depressive symptoms. Ages 65 and over. Location in Philadelphia, PA.
  • Reducing Symptoms of Depression in Low-Income Mothers.
    Interventional study. This study will test the effectiveness of a short-term intervention in treating depressed young mothers with young children enrolled in Early Head Start Programs. Ages 15 and over. Locations in Asheville, NC; Chapel Hill, NC; Goldsboro, NC; Greensboro, NC; Syracuse, NY.
  • Preventing Post-Stroke Depression.
    Interventional study. This study will evaluate the effectiveness of both drug and non-drug treatments in preventing depression after a stroke. Ages 31-89. Locations in Iowa City, IA; Chicago, IL; White Plains, NY.

Search ClinicalTrials.gov for other NIH studies on Depression.